Autres langues Chugai Pharmaceutical Co., Ltd

Actions

4519

JP3519400000

Temps Différé Japan Exchange Autres places de cotation 04:30:00 14/05/2024			Varia. 5j.	Varia. 1 janv.
4 733 ^JPY	-4,69 %		-5,02 %	-11,36 %

07/05	Galderma, gros peautentiel ?
25/04	Roche, la société mère de Chugai Pharmaceutical, enregistre une baisse des ventes au premier trimestre ; l'action chute de 5%.	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Galderma Group AG: groot potentieel?	09/05
Chugai, NCCH, OMPU and MICIN Start Company-Sponsored Phase I Study in Oncology with a New Decentralized Clinical Trial Structure, Improving access to the clinical trial for patients far from the institution	09/05
Galderma, un grande potenziale?	08/05
Galderma Group AG: Potenzial in der Hautpflege	07/05
Galderma Group AG: ¿Un gran potencial?	07/05
Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation	01/05
Chugai Pharmaceutical : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan	26/04
Chugai Announces 2024 1st Quarter Results	25/04
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	25/04
Chugai Pharmaceutical's Profit Slightly Up in Q1	24/04
Chugai Pharmaceutical : Q1 Results (Jan-Mar 2024)	24/04
Chugai Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending December 31, 2024; Provides Dividend Guidance for the Year Ending December 31, 2024	24/04
Chugai Pharmaceutical : F. Hoffmann-La Roche Announces First Quarter Sales 2024	24/04
Chugai Pharmaceutical Co., Ltd. - Positive Phase III Results Showed Vabysmo Improved Vision for the First Time in Japanese in Angioid Streaks	15/04
Chugai Pharmaceutical Co., Ltd. - Relief Efforts Support for Earthquake off the Eastern Coast of Taiwan	10/04
MÄRKTE ASIEN/Uneinheitlich vor US-Inflationsdaten - Hongkong deutlich im Plus	10/04
Japan's Nikkei slips on caution ahead of US inflation data	10/04
Chugai Pharmaceutical to Allocate 594 Million Yen of Treasury Shares as Restricted Stock Compensation	29/03
Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile to Be Used as a Companion Diagnostic for the AKT Inhibitor, Capivasertib for Advanced HR-positive, HER2-negative Breast Cancer	28/03
Chugai Pharmaceutical : Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan	28/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Chugai Pharmaceutical Co., Ltd

Actions

4519

JP3519400000

Autres langues

Filtres